Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

Published:2008-05-22 Issue:7 Volume:24 Page:1877-1890
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Liebowitz Michael R.¹,Manley Amy L.²,Padmanabhan Sudharshan K.²,Ganguly Rita²,Tummala Raj²,Tourian Karen A.²

Affiliation:

1. Columbia University, New York, NY, USA

2. Wyeth Research, Collegeville, PA, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007990802161923

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Desvenlafaxine in Reducing Migraine Frequency and Severity: A Retrospective Study;Journal of Clinical Medicine;2024-08-30

2. Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine;Pharmaceuticals;2024-01-03

3. Novel radioiodinated desvenlafaxine‐loaded lipid nanocapsule for brain delivery;Archiv der Pharmazie;2023-12-31

4. Practical pathway for the management of depression in the workplace: a Canadian perspective;Frontiers in Psychiatry;2023-09-05

5. Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper;Expert Opinion on Pharmacotherapy;2023-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP